Related Experiment Video
Updated: Feb 1, 2026

Electrocardiogram Recordings in Anesthetized Mice using Lead II
Published on: June 20, 2020
Using Medicaid Data to Improve Childhood Lead Poisoning Prevention Program Outcomes and Blood Lead Surveillance
Shelley A Bruce1, Krista Y Christensen, Marjorie J Coons
1Division of Public Health, Department of Health Services, Madison, Wisconsin (Ms Bruce, Dr Meiman, and Ms Walsh); and Departments of Ophthalmology and Visual Sciences (Dr Christensen), Population Health Sciences (Ms Coons), and Surgery (Mr Havlena), School of Medicine and Public Health, University of Wisconsin, Madison.
Insights
Wisconsin
Area of Science:
- Public Health
- Environmental Health
- Pediatrics
Background:
- Medicaid mandates blood lead screening for children.
- Wisconsin law requires reporting of all blood lead tests.
- Inconsistent testing and reporting were identified.
Purpose of the Study:
- Improve blood lead testing compliance among Medicaid providers.
- Enhance blood lead surveillance through accurate reporting.
Main Methods:
- Linked Medicaid billing data with blood lead test results.
- Used provider report cards to track testing compliance.
- Contacted providers to obtain missing blood lead test reports.
Main Results:
- Childhood blood lead testing increased by 31% from 2006 to 2010.
- Age-appropriate testing rose from 46% to 55% for Medicaid children.
- Over 9,000 unreported blood lead tests were identified, primarily from outpatient clinics.
Conclusions:
- Medicaid data effectively boosts lead testing and surveillance.
- Healthcare providers must ensure timely, age-appropriate lead screening.
- Outpatient clinics require targeted interventions to improve test reporting.
Context:
Wisconsin-specific data revealed that not all Medicaid providers were testing children appropriately for blood lead levels and not all blood lead tests were reported to the Department of Health Services, Childhood Lead Poisoning Prevention Program. The Medicaid program requires blood lead screening for all Medicaid-enrolled children at specific ages. Wisconsin state law requires reporting of all blood lead test results. Projects were implemented to encourage appropriate testing for Medicaid-enrolled children and improve blood lead surveillance.
Methods:
Medicaid billing data were linked to blood lead data to identify Medicaid-enrolled children who had not received the required tests. Medicaid provider report cards were distributed annually from 2006 to 2011 to inform providers of their compliance with federal testing requirements and of the names of children within their practice who had not been tested. Blood lead tests billed to Medicaid but not in the blood lead database were identified and billing providers were contacted to obtain the test report.
Results:
The number of children tested increased from 81 834 children per year in 2006 to 106 003 children per year in 2010. Testing of Medicaid-enrolled children increased by 31% from 2006 to 2010. The percentage of Medicaid-enrolled children receiving an age-appropriate test increased from 46% in 2004 to a high of 55% in 2010. There were 9035 blood lead tests identified in the Medicaid billing data that had not been reported from 2007 to 2015. There were 468 billing providers who had unreported tests. All sites with unreported tests were contacted, 84% of test results were obtained, and 14% of test records could not be retrieved. Outpatient clinics accounted for the majority of all unreported tests (72%) and irretrievable test records (74%).
Discussion:
Childhood lead poisoning prevention programs can effectively utilize Medicaid data to increase testing and improve blood lead surveillance. Primary health care providers should ensure that Medicaid-enrolled children in their care receive the age-appropriate tests. Many Wisconsin health care providers lack awareness of blood lead test reporting requirements. Outpatient clinics account for the largest proportion of unreported tests and highest priority should be given working with these sites to improve reporting practices.
Related Concept Videos
Prevention of Further Absorption of Poison
Phase-lead and Phase-lag Controllers
Time and frequency -Domain Interpretation of Phase-lead Control
The design of phase-lead control involves the strategic placement of poles and zeros to balance steady-state error and system...
Enhanced Elimination of Poison
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Principles of Disease Surveillance

